Cargando…
LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
Gastric cancer (GC), a malignant tumor of digestive tract, is characterized by a high death rate. Thus, it is of particular importance to clarify the mechanisms of GC and gain new molecular targets for the sake of preventing and treating GC. It was reported that long non-coding RNAs (IncRNAs) are pr...
Autores principales: | Liu, Jun-Yan, Yao, Jing, Liu, Jia-Jia, He, Tao, Wang, Fang-Jie, Xie, Tian-Yu, Cui, Jian-Xin, Yang, Xiao-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557225/ https://www.ncbi.nlm.nih.gov/pubmed/36249015 http://dx.doi.org/10.3389/fonc.2022.1020255 |
Ejemplares similares
-
Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer
por: Bai, Maoshu, et al.
Publicado: (2023) -
Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
por: Qian, Yawei, et al.
Publicado: (2023) -
Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence
por: Zhou, Cen, et al.
Publicado: (2019) -
GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer
por: Wang, Jinyun, et al.
Publicado: (2023) -
Prognostic and Predictive Value of BGN in Colon Cancer Outcomes and Response to Immunotherapy
por: He, Zi-Xuan, et al.
Publicado: (2022)